THE "GRAY-COLORED
TUMOR" OF alpha-methyl-dopa treatment and not proven to have pheochromocytoma have been the basis for "normal" values. At least two of these patients with values considered "normal" have undergone celiotomy and an abdominal pheochromocytoma was not found. Multiple follow-up studies have indicated the others not to have the tumor.
THE ADRENAL medulla has fascinated physicians for 80 years. The diagnosis in the past has been hazardous and error prone. The variety of diagnostic measures currently recommended suggest there has been little consensus on the best approach. The purpose of this presentation is to give our convictions on definitive diagnosis based on 6 years' experience in a highly specialized laboratory in a large medical center. By definitive diagnosis is meant sufficient confidence in the results to operate on the patient without further diagnostic investigation. 
MATERIALS

METHODS
When a pheochromocytoma is to be ruled out, two 12-hr overnight urine specimens are collected in a tinted bottle containing 10 ml 6 N HCl acid to keep the pH less than 3.0. Free catecholamines (epinephrine and norepinephrine) and metanephrine metabolites (metanephrine and normetanephrine) are measured using fluorometric trihydroxyindole methods of biochemical determination [4, 121. Alpha-methyl-dopa treatment of hypertension must be ruled out in every case because it has been found to falsely elevate both free catecholamine [6] and metanephrine metabolite values to diagnostic range for at least 2 weeks. No diet restrictions are imposed. Outpatient collections are readily made. Specimens sent by public conveyance have been acceptable as long as the urine pH remains below 3 [5] .
When the definitive diagnosis has been made, attempts at localization are often done (chest X-ray, IVP, venogram, caval catheterization, arteriogram, and 1311 cholesterol scan) but have not been considered essential in uncomplicated cases.
14, NO. 3, AIARCH 197s Table 1 shows the mean urinary levels in nonpheochromocytoma hypertensives to be norepinephrine 28.9 4 29.0" pg/24 hr, epinephrine 7.6 +-7.4 pg/24 hr, normetanephrine 44.2 + 38.9 pg/24 hr, metanephrine 32.9 k 16.4 pg/24 hr. These are compared to the mean values found in proven pheochromocytoma patients, norepinephrine 1250 k 2456 pg/24 hr, epinephrine 238 I 408 pg/24 hr, normetanephrine 1127 +-842 pg/24 hr, and metanephrine 1305 -+ 1708 ,ug/24 hr. All four group comparisons with Student's t test show P < 0.001. High normal limits for 95% confidence could be considered to be the mean plus 2 SD. Anything above this we consider suspicious but the diagnostic range has occurred at 5 SD in excess of the normal mean.
Using these criteria, urinary norepinephrine and epinephrine were diagnostic in 90% of all overnight urine collections in proven cases with 2% falsely positive in nonpheochromocytoma hypertensives. All 29 urine samples tested for metanephrine metabolites were diagnostic with approxi-* +l Standard Deviation., mately 5% falsely positive ( Pertsemlidis et al. [14] that more than one mcasurcment of several urinary products is sufficient for diagnosis and disagree with Mahoney et al. [ 131 that multiple methods be utilized as well as multiple determinations with each technique. The interfering medication, alpha-methyl-dopa, must be ruled out, as well as severe strcssea such as large thermal burns. In our laboratory we have found that al~~l~a-metl~yl-clo1,:1 cannot only elevate the catecholamines but the metanephrine mctabolites as well to diagnostic range.
The overnight 12-hr resting collection has been very satisfactory. Unusual stress and activity is avoided and the convenience for the patient results in more accurate collection.
Since Crout's suggestion in 1961 [3] that metanephrine metabolitcs be measured, it has been shown to be of excellent diagnostic support [ 2, 7, 10, 141. Our results have been most encouraging. No patient with a pheochromocytoma has had a single negative urine for both metanephrine or normctanephrine.
Provocative and suppressive pharmacologic studies have no place in modern pheochromocytoma diagnosis. The definite dangers and gross inaccuracies are documented in almost every report on this subject.
Tumor localization after the diagnosis has been made is often done to help cstablish whether or not there is more than one lesion. Efforts at localization in this institution have been previously published 1111.
SUMMARY
Based on urinary studies of patients with pheochromocytoma as compared to hypertcnsives considered to be without this tumor, rigorous biochemical criteria for diagnosis are proposed. Free catecholamines in 90% and mctanephrine metabolites in 100% of the pheochromocytoma patients' urine samples exceeded the normal (hypertensive) values by more than 5 SD. No patient without pheochromocytoma has falsely positive values in both free catecholaminc and metanephrine mctabolite determinations. So patient with a pheochromocytoma had a urine sample negative for mctancphrinc~ metabolitcs. The combination of these studies has given excellent accuracy for dcfinitivc diagnosis.
